ASE · Medical - Devices

VTAK (VTAK) Stock

$0.28 -3.45% ASE: VTAK Healthcare

Valuation

MetricValue
Price$0.28
Market Cap$302533
P/E Ratio-0.05
P/B Ratio0.12
P/S Ratio0.98
EPS (TTM)$-15.90
52-Week High$5.70
52-Week Low$0.25
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE-242.86%
ROA-106.25%
ROCE-171.43%
Gross Margin-1200.00%
Operating Margin-1200.00%
Net Margin-18.81%
Debt/Equity1.25
Current Ratio0.06

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$1.0M
Operating Profit$-29.0M$-27.0M$-78.0M$-11.0M$-12.0M
Net Profit$-25.0M$-27.0M$-71.0M$-17.0M$-17.0M
EPS$-248.22$-25.98$-12.99$-6.68$-15.90
Op Margin-133027.3%-192578.6%-17674.0%-2676.9%-1487.3%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$21.0M$17.0M$31.0M$28.0M$16.0M
Total Liabilities$7.0M$8.0M$10.0M$16.0M$9.0M
Cash$15.0M$16.0M$4.0M$3.0M$0
Borrowings$2.0M$0$0$2.0M$4.0M

Latest News

Catheter Precision's Fly Flyte, Blade Urban Air Mobility to Expand Vision Jet Distribution MT Newswires · Jul 21, 2026 Flyte Partners with Blade to Expand Vision Jet Distribution GlobeNewswire · Jul 21, 2026 VTAK Announces Preliminary Second Quarter Record Revenue in Excess of $1 million GlobeNewswire · Jul 15, 2026 Top Premarket Decliners MT Newswires · Jul 9, 2026 Catheter Precision's Fly Flyte Unit Teams Up With LifeVac to Equip Jets With Choking Rescue Device MT Newswires · Jul 7, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-28.0M$-23.0M$-21.0M$-9.0M$-8.0M
Investing Cash Flow$4.0M$0$0$0$0
Financing Cash Flow$0$4.0M$1.0M$1.0M$0
Net Cash Flow$-9.0M$1.0M$-12.0M$-1.0M$-3.0M
Free Cash Flow$-28.0M$-23.0M$-21.0M$-9.0M$-8.0M

Valuation & Return Ratios

MetricValue
PEG Ratio—
EV / EBITDA—
FCF Yield-1045.85%
Quick Ratio0.06
Interest Coverage—
Return 1Y-86.12%
Return 3Y-99.59%
Return 5Y-100.00%

Ownership

Insiders Held11.24%
Institutions Held4.47%
Institutions Float Held5.04%
Institutional HolderSharesReport Date
Geode Capital Management, LLC47,6592026-03-31
Virtu Financial LLC13,4722026-03-31
Millennium Management Llc13,1372026-03-31
Jane Street Group, LLC11,3792026-03-31
HRT Financial LP11,2762026-03-31

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AAPLApple Inc. $313.33 +0.29% 37.72 $4.60T 0.34%
MSFTMicrosoft Corporation $499.99 +0.03% 22.95 $3.71T 0.94%
GOOGLAlphabet Inc. $354.30 -0.96% 27.68 $4.29T 0.23%
AMZNAmazon.com, Inc. $274.48 +0.82% 28.76 $2.95T 0.00%
METAMeta Platforms, Inc. $592.10 +0.37% 21.47 $1.51T 0.35%

About VTAK

VTAK is led by CEO David A. Jenkins, employs 22 people, headquartered in US, publicly traded since 2018.

VTAK stock trades at $0.28 with a market capitalization of $302533. The stock is valued at a price-to-earnings (P/E) ratio of -0.05, price-to-book of 0.12, price-to-sales of 0.98. Over the past 52 weeks the stock has ranged between $0.25 and $5.70, and currently trades 95.1% below its 52-week high.

On profitability, VTAK generates a return on equity (ROE) of -242.86%, return on capital employed of -171.43%, an operating margin of -1200.00%, a net profit margin of -18.81%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksAll stock screens
Run Stock Screener Investing Guides